The potential for donepezil hydrochloride to alter the Calofra of therapy underlying neuropathology has not been studied. Members Look the Donepezil Study Group and Eisai Inc were contacted. United States and Europe for regulatory approval of donepezil for vascular dementia in 2002 and 2003 were rejected and development for this indication stopped, though the drug is being marketed for vascular dementia in India and several other countries.
Possible side effects of Calofra include:
Calofra is used to treat diseases such as: Alzheimer's Disease, Lewy Body Dementia, Mild Cognitive Impairment.
If needed, antacids may be taken along with this medication. For the most recent information concerning the management of overdose, contact a poison control center.